Cargando…

Alpha-1-antichymotrypsin as a novel biomarker for diagnosis, prognosis, and therapy prediction in human diseases

The glycoprotein alpha-1-antichymotrypsin (AACT), a serine protease inhibitor, is mainly synthesized in the liver and then secreted into the blood and is involved in the acute phase response, inflammation, and proteolysis. The dysregulation of AACT and its glycosylation levels are associated with tu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jin, Yanxia, Wang, Weidong, Wang, Qiyun, Zhang, Yueyang, Zahid, Kashif Rafiq, Raza, Umar, Gong, Yongsheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019971/ https://www.ncbi.nlm.nih.gov/pubmed/35439996 http://dx.doi.org/10.1186/s12935-022-02572-4

Ejemplares similares

Expression of alpha-1-antichymotrypsin in prostate carcinoma.
por: Cho, N. H., et al.
Publicado: (1997)

A clinical perspective on the utility of alpha 1 antichymotrypsin for the early diagnosis of calcific aortic stenosis
por: Martin-Rojas, Tatiana, et al.
Publicado: (2017)

Urinary α(1)-Antichymotrypsin: A Biomarker of Prion Infection
por: Miele, Gino, et al.
Publicado: (2008)

Identification of GlcNAcylated alpha-1-antichymotrypsin as an early biomarker in human non-small-cell lung cancer by quantitative proteomic analysis with two lectins
por: Jin, Yanxia, et al.
Publicado: (2016)

Elevated plasma α1-antichymotrypsin is a biomarker candidate for malaria patients
por: Bahk, Young Yil, et al.
Publicado: (2022)

Plasma levels of alpha-1-antichymotrypsin are elevated in patients with chronic heart failure, but are of limited prognostic value
por: Lok, S. I., et al.
Publicado: (2014)

A Coronary Artery Disease Monitoring Model Built from Clinical Data and Alpha-1-Antichymotrypsin
por: Chang, Chen-Chi, et al.
Publicado: (2022)

Synthesis and release of platelet-activating factor is inhibited by plasma alpha 1-proteinase inhibitor or alpha 1-antichymotrypsin and is stimulated by proteinases
Publicado: (1988)

Alpha-1 antichymotrypsin is involved in astrocyte injury in concert with arginine-vasopressin during the development of acute hepatic encephalopathy
por: Park, Jonghyuk, et al.
Publicado: (2017)

Glycoproteoform Profiles of Individual Patients’ Plasma Alpha-1-Antichymotrypsin are Unique and Extensively Remodeled Following a Septic Episode
por: Čaval, Tomislav, et al.
Publicado: (2021)

Is Alpha-1 Antichymotrypsin Gene Polymorphism a Risk Factor for Primary Intracerebral Hemorrhage? A Case-Control Study and Meta-Analysis
por: Hu, Xin, et al.
Publicado: (2015)

mTOR/HDAC1 Crosstalk Mediated Suppression of ADH1A and ALDH2 Links Alcohol Metabolism to Hepatocellular Carcinoma Onset and Progression in silico
por: Zahid, Kashif Rafiq, et al.
Publicado: (2019)

Reactive astrocytes transduce inflammation in a blood-brain barrier model through a TNF-STAT3 signaling axis and secretion of alpha 1-antichymotrypsin
por: Kim, Hyosung, et al.
Publicado: (2022)

Alpha 1-Antichymotrypsin, an Inflammatory Protein Overexpressed in the Brains of Patients with Alzheimer's Disease, Induces Tau Hyperphosphorylation through c-Jun N-Terminal Kinase Activation
por: Tyagi, Ethika, et al.
Publicado: (2013)

Systems biology based meth-miRNA–mRNA regulatory network identifies metabolic imbalance and hyperactive cell cycle signaling involved in hepatocellular carcinoma onset and progression
por: Zahid, Kashif Rafiq, et al.
Publicado: (2019)

Neutrophils: Musketeers against immunotherapy
por: Zahid, Kashif Rafiq, et al.
Publicado: (2022)

Plasma levels of alpha1-antichymotrypsin and secretory leukocyte proteinase inhibitor in healthy and chronic obstructive pulmonary disease (COPD) subjects with and without severe α1-antitrypsin deficiency
por: Hollander, Camilla, et al.
Publicado: (2007)

Hypoxia-driven ncRNAs in breast cancer
por: H. Al-Zuaini, Hashim, et al.
Publicado: (2023)

Overexpression of SERPINA3 suppresses tumor progression by modulating SPOP/NF-κB in lung cancer
por: Jin, Yanxia, et al.
Publicado: (2023)

Novel biomarkers for the diagnosis and prognosis of colorectal cancer
por: Oh, Hyung-Hoon, et al.
Publicado: (2020)

Novel biomarkers for diagnosis, prognosis, targeted therapy and clinical trials
por: Hsueh, Chung-Tsen, et al.
Publicado: (2013)

Tubulin Alpha-1b as a Potential Biomarker for Lung Adenocarcinoma Diagnosis and Prognosis
por: Pang, Xue-Li, et al.
Publicado: (2023)

Novel Biomarker for the Diagnosis and Prognosis of Acute Alcoholic Hepatitis
por: Vatsalya, Vatsalya
Publicado: (2020)

TMEM147 is a novel biomarker for diagnosis and prognosis of hepatocellular carcinoma
por: Fan, Wen-Jie, et al.
Publicado: (2023)

Structure and functions of Mer, an innate immune checkpoint
por: Ubil, Eric, et al.
Publicado: (2023)

Solid Serous Cystadenoma of the Pancreas: A Case Report of 2 Patients Revealing Vimentin, β-Catenin, α-1 Antitrypsin, and α-1 Antichymotrypsin as New Immunohistochemistry Staining Markers
por: Wu, Wenming, et al.
Publicado: (2015)

Cysteine cathepsin C: a novel potential biomarker for the diagnosis and prognosis of glioma
por: Cheng, Xingbo, et al.
Publicado: (2022)

Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Hu, Xiaoyi, et al.
Publicado: (2020)

Novel Biomarkers and Their Role in the Diagnosis and Prognosis of Acute Coronary Syndrome
por: Katsioupa, Maria, et al.
Publicado: (2023)

Serum alpha-fetoprotein as a predictive biomarker for tissue alpha-fetoprotein status and prognosis in patients with hepatocellular carcinoma
por: Wei, Zhewen, et al.
Publicado: (2022)

Plasma specific miRNAs as predictive biomarkers for diagnosis and prognosis of glioma
por: Wang, Qiong, et al.
Publicado: (2012)

Dynamic Change in Serum Alpha-fetoprotein Level Predicts Treatment Response and Prognosis of Alpha-fetoprotein-producing Gastric Cancer
por: Wang, Ruhan, et al.
Publicado: (2020)

A novel class of tsRNA signatures as biomarkers for diagnosis and prognosis of pancreatic cancer
por: Jin, Fangfang, et al.
Publicado: (2021)

Apoptosis-associated biomarkers in tuberculosis: promising for diagnosis and prognosis prediction
por: Shu, Chin-Chung, et al.
Publicado: (2013)

KIN17 promotes tumor metastasis by activating EMT signaling in luminal‐A breast cancer
por: Huang, Qiyuan, et al.
Publicado: (2021)

Identification of a long non-coding RNA signature for predicting prognosis and biomarkers in lung adenocarcinoma
por: Yu, Xiaolin, et al.
Publicado: (2020)

Corrigendum: Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Hu, Xiaoyi, et al.
Publicado: (2020)

Exosomal Components and Modulators in Colorectal Cancer: Novel Diagnosis and Prognosis Biomarkers
por: Chang, Yu-Chan, et al.
Publicado: (2021)

LncRNAs serve as novel biomarkers for diagnosis and prognosis of childhood ALL
por: Huang, Xuanmei, et al.
Publicado: (2021)

Long non-coding RNA HULC as a novel serum biomarker for diagnosis and prognosis prediction of gastric cancer
por: Jin, Chunjing, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ip5v6js5480l2t3ujfhoqcf6a7